Meri Kaustio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meri Kaustio has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Janna Saarela
Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland
6 shared publications Jaana Syrjänen
Infectious Disease Unit, Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
3 shared publications- Eliisa Kekäläinen
Translational Immunology Research Program University of Helsinki and Helsinki University Hospital Helsinki Finland
2 shared publications - Heinrich Schlums
Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Iivo Hetemäki
Translational Immunology Research Program University of Helsinki and Helsinki University Hospital Helsinki Finland
2 shared publications - Johannes Dunkel
MediCity Research Laboratory, University of Turku, Turku, Finland
2 shared publications
Latest Publications
- Open Access
- 25 July 2025
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 156 (4) , 1024-1037
Heterozygous loss of MAP4K1 causes immune dysregulation by amplifying T-cell responses
- 25 July 2025
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 156 (4) , 1024-1037
Open AccessHeterozygous loss of MAP4K1 causes immune dysregulation by amplifying T-cell responses
- Open Access
- 3 April 2023
- Published by Elsevier in JID Innovations
- Vol. 3 (4) , 100203
Relevance of Coding Variation in FLG And DOCK8 in Finnish Pediatric Patients with Early-Onset Moderate-To-Severe Atopic Dermatitis
- 3 April 2023
- Published by Elsevier in JID Innovations
- Vol. 3 (4) , 100203
Open AccessRelevance of Coding Variation in FLG And DOCK8 in Finnish Pediatric Patients with Early-Onset Moderate-To-Severe Atopic Dermatitis
- 26 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 6 (65) , eabe3454
Loss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells
A truncated variant of Helios causes a human immunodeficiency disease with signs of immune overactivation.
- 26 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 6 (65) , eabe3454
Loss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells
A truncated variant of Helios causes a human immunodeficiency disease with signs of immune overactivation.
- Open Access
Loss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells
The IKAROS family transcription factors regulate lymphocyte development. Loss-of-function variants in IKZF1 cause primary immunodeficiency, but IKAROS family members IKZF2 and IKZF3 have not yet been associated with immunodeficiency yet. Here, we describe a pedigree with a heterozygous truncating variant in IKZF2 , encoding the translational activator and repressor HELIOS which is highly expressed in regulatory T cells and effector T cells, particularly of the CD8 + T cell lineage. Protein-protein interaction analysis revealed that the variant abolished HELIOS dimerizations as well as binding to members of the Mi-2/NuRD chromatin remodeling complex. Patients carrying the IKZF2 variant presented with a combined immunodeficiency phenotype characterized by recurrent upper respiratory infections, thrush and mucosal ulcers, as well as chronic lymphadenopathy. With extensive immunophenotyping, functional assays, and transcriptional analysis we show that reduced HELIOS expression was associated with chronic T cell activation and increased production of pro-inflammatory cytokines both in effector and regulatory T cells. Lymph node histology from patients indicated dysregulated germinal center reactions. Moreover, affected individuals displayed profoundly reduced circulating MAIT cell numbers. In summary, we show that this novel loss-of-function variant in HELIOS leads to an immunodeficiency with signs of immune overactivation. One sentence summary: Truncating variant of HELIOS causes immunodeficiency with signs of immune overactivation.
Open AccessLoss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells
The IKAROS family transcription factors regulate lymphocyte development. Loss-of-function variants in IKZF1 cause primary immunodeficiency, but IKAROS family members IKZF2 and IKZF3 have not yet been associated with immunodeficiency yet. Here, we describe a pedigree with a heterozygous truncating variant in IKZF2 , encoding the translational activator and repressor HELIOS which is highly expressed in regulatory T cells and effector T cells, particularly of the CD8 + T cell lineage. Protein-protein interaction analysis revealed that the variant abolished HELIOS dimerizations as well as binding to members of the Mi-2/NuRD chromatin remodeling complex. Patients carrying the IKZF2 variant presented with a combined immunodeficiency phenotype characterized by recurrent upper respiratory infections, thrush and mucosal ulcers, as well as chronic lymphadenopathy. With extensive immunophenotyping, functional assays, and transcriptional analysis we show that reduced HELIOS expression was associated with chronic T cell activation and increased production of pro-inflammatory cytokines both in effector and regulatory T cells. Lymph node histology from patients indicated dysregulated germinal center reactions. Moreover, affected individuals displayed profoundly reduced circulating MAIT cell numbers. In summary, we show that this novel loss-of-function variant in HELIOS leads to an immunodeficiency with signs of immune overactivation. One sentence summary: Truncating variant of HELIOS causes immunodeficiency with signs of immune overactivation.
- Open Access
- 1 August 2021
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 148 (2) , 599-611
Loss of DIAPH1 causes SCBMS, combined immunodeficiency, and mitochondrial dysfunction
- 1 August 2021
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 148 (2) , 599-611
Open AccessLoss of DIAPH1 causes SCBMS, combined immunodeficiency, and mitochondrial dysfunction
- 1 April 2016
- Published by Elsevier in Clinical Immunology
- Vol. 165, 19-20
Constant B cell lymphocytosis since early age in a patient with CARD11 mutation: A 20-year follow-up
- 1 April 2016
- Published by Elsevier in Clinical Immunology
- Vol. 165, 19-20
Constant B cell lymphocytosis since early age in a patient with CARD11 mutation: A 20-year follow-up